STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS - Netherlands 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:400-500
Total Number of Projects:600-700
2019
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:> 1000
Total Number of Projects:900-1000
2018
Criterium:Position:
Overall Score:700-800
Total Project Funding per Partner:300-400
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2017
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:100-200
Total Number of Projects:400-500
Networking Rank (Reputation):400-500
2016
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:400-500
Total Number of Projects:500-600
Networking Rank (Reputation):900-1000
2015
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:300-400
Total Number of Projects:300-400
Networking Rank (Reputation):800-900
Partner Constancy:100-200
Project Leadership Index:700-800

Ranking timeline:

Project Participation Performance(2015-01-01 - 2022-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 51
As coordinator: 4
As participant: 36
Sole participant: 11
Coordinator / Participant Ratio: 0.11*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 363.197 46.037.867 3.185.937 2 7
2021 175.572 45.377.216 653.473 1 3
2020 12.160.741 26.917.412 3.989.449 3 4
2019 2.778.359 15.301.106 4.222.608 2 4
2018 6.427.900 5.156.199 6.857.225 3 1
2017 4.902.750 27.880.498 5.907.395 2 5
2016 0 37.644.785 2.479.874 6
2015 7.983.356 25.769.292 6.071.026 2 6

Networking:

Partners:

Institution:Projects [No]:
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE11
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS9
EUROPEAN MOLECULAR BIOLOGY LABORATORY9
KAROLINSKA INSTITUTE8
KATHOLIEKE UNIVERSITEIT LEUVEN8
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM7
MASARYKOVA UNIVERZITA7
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON6
UNIVERSITAIR MEDISCH CENTRUM UTRECHT6
ACADEMISCH ZIEKENHUIS GRONINGEN5
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM5
CONSIGLIO NAZIONALE DELLE RICERCHE5
ACADEMISCH ZIEKENHUIS LEIDEN4
COMMISSARIAT A L'ENERGIE ATOMIQUE4
CONSORZIO INTERUNIVERSITARIO RISONANZE MAGNETICHE DI METALLOPROTEINE PARAMAGNETICHE4
DEUTSCHES KREBSFORSCHUNGSZENTRUM4
EATRIS ERIC4
EUROPEAN CANCER PATIENT COALITION4
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT4
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE4
INSTITUT PASTEUR4
LEIDS UNIVERSITAIR MEDISCH CENTRUM4
STICHTING LYGATURE4
THE UNIVERSITY OF MANCHESTER4
UNIVERSIDADE NOVA DE LISBOA4
UNIVERSITA DEGLI STUDI DI TORINO4
UNIVERSITEIT UTRECHT4
UNIVERSITY OF COPENHAGEN4
CSC TIETEEN TIETOTEKNIIKAN KESKUS OY3
DIAMOND LIGHT SOURCE LIMITED3
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK3
EUROPEAN INFRASTRUCTURE OF OPEN SCREENING PLATFORMS FOR CHEMICAL BIOLOGY EUROPEAN RESEARCH INFRASTUCTURE CONSORTIUM3
IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON3
INFRAFRONTIER3
INSTITUT CATALA D'ONCOLOGIA3
INSTITUT CURIE3
INSTRUCTERIC3
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN3
MEDIZINISCHE UNIVERSITAET WIEN3
OTTOVONGUERICKEUNIVERSITAET MAGDEBURG3
OULUN YLIOPISTO3
PANEPISTIMIO KRITIS3
PHILIPPS UNIVERSITAET MARBURG3
PHILIPS ELECTRONICS NEDERLAND BV3
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD3
UNITED KINGDOM RESEARCH AND INNOVATION3
UNIVERSITAET ZUERICH3
UNIVERSITAETSKLINIKUM HEIDELBERG3
UNIVERSITE DE GENEVE3
UNIVERSITE DE LIEGE3
UNIVERSITY OF AARHUS3
UNIVERSITY OF OSLO3
UNIVERSITY OF PATRAS3
USTAV MOLEKULARNI GENETIKY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYSKUMNA INSTITUCE3
WAGENINGEN UNIVERSITY3
BAYER2
CENTRE DE REGULACIO GENOMICA2
CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET EN MEDECINE2
CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE2
CHARITE UNIVERSITAETSMEDIZIN BERLIN2
CHARLES UNIVERSITY PRAGUE2
DANMARKS TEKNISKE UNIVERSITET2
DEUTSCHE SPORTHOCHSCHULE KOLN2
EIDGENOESSISCHES DEPARTEMENT DES INNERN2
EOTVOS LORAND TUDOMANYEGYETEM2
EUROBIOIMAGING ERIC2
FORSCHUNGSVERBUND BERLIN EV2
FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS2
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V2
FUNDACIO CENTRE DE REGULACIO GENOMICA2
FUNDACIO INSTITUT DE RECERCA BIOMEDICA2
FUNDACION ONKOLOGIKOA FUNDAZIOA2
FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III2
GENOME RESEARCH2
HELMHOLTZZENTRUM FUR INFEKTIONSFORSCHUNG2
HELSINGIN JA UUDENMAAN SAIRAANHOITOPIIRIN KUNTAYHTYMAE2
IFOM FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE2
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2
INSERM TRANSFERT2
INSTITUT DE RADIOPROTECTION ET DE SURETE NUCLEAIRE2
INSTITUT DE RECERCA I TECNOLOGIA AGROALIMENTARIES2
INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT2
INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE L'ALIMENTATION ET L'ENVIRONNEMENT2
INSTITUT PASTEUR DE DAKAR2
INSTITUT PASTEUR DE NOUVELLECALEDONIE2
INSTITUTO NACIONAL DE SAUDE DR RICARDO JORGE2
INSTITUTO POLITECNICO DE COIMBRA2
INSTRUCT ACADEMIC SERVICES LIMITED2
INTERUNIVERSITAIR MICRO ELECTRONICA CENTRUM VZW2
ISTITUTO EUROPEO DI ONCOLOGIA2
ISTITUTO SUPERIORE DI SANITA2
JANSSEN PHARMACEUTICA NV2
JOANNEUM RESEARCH FORSCHUNGSGESELLSCHAFT MBH2
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT2
JULIUS CLINICAL RESEARCH BV2
KAROLINSKA INSTITUTET2
KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN KNAW2
LEIDEN UNIVERSITY2
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV2
MEDICAL RESEARCH COUNCIL2

Constancy:

Total number of partners: 790
Partner loyalty:
Frequent Partner: (> 2 projects): 231
Rare Partner: 559
Frequent / Rare Partner Ratio: 0.41

Project overview:

Start dateProjectacronymrolefundingpartners
2022-12-01Implementing value-based oncology care at European cancer hospitals: An AI-based framework for assessing real-life effectiveness of novel cancer therapies in real-time ONCOVALUEparticipant6.953.00411
2022-11-01PREFERABLE-II - Personalised Exercise-Oncology for improvement of supportive care: a super umbrella trial to demonstrate the (cost)effectiveness of live-remote exercise in cancer survivors PREFERABLE-IIparticipant5.925.46314
2022-10-01DNA replication at the heart of cell fate decisions and cancer development RepliFateparticipant2.650.31321
2022-10-01Role of astrogliosis in the recurrence of brain tumors after microsurgical resection GlioSurgparticipant195.9152
2022-10-01TWINNING FOR A EUROPEAN CONSORTIUM OF RECTAL CANCER RESEARCH INSTITUTIONS THROUGH STEPPING UP SCIENTIFIC, TECHNOLOGICAL AND INNOVATION EXCELLENCE OF IORS STEPUPIORSparticipant1.500.0005
2022-09-01A European-wide foundation to accelerate Data-driven Cancer Research EOSC4Cancerparticipant7.814.54934
2022-09-01Dissecting how breast cancer-associated inflammation shapes invariant natural killer T cell activity during metastatic progression BreaKercoordinator175.5721
2022-07-01Understanding aneuploidy tolerance in cancer by studying early embryogenesis OncoFetal_Ploidycoordinator187.6242
2022-02-01Integrated Services for Infectious Disease Outbreak Research ISIDOReparticipant20.998.624154
2021-12-01From chromatin fibers to lamina-associated domains: what are the recognition determinants? I.am.a.LADcoordinator175.5721
2021-07-01Building a reproducible single-cell experimental workflow to capture tumour drug persistence PERSIST-SEQparticipant7.057.98016
2021-02-01Building Data Rich Clinical Trials CCE_DARTparticipant5.999.41112
2021-02-01Central Repository for Digital Pathology BIGPICTUREparticipant32.319.82551
2020-09-01EURopeAn MEDical application and Radiation prOteCtion Concept: strategic research agenda aNd ROadmap interLinking to heaLth and digitisation aspects EURAMED rocc-n-rollparticipant1.959.17529
2020-09-01Deconstructing gene regulation through functional dissection of the 3D genome FuncDis3Dcoordinator1.997.4251
2020-09-01TWISTING THE BOUNDARIES: ROLE OF TOPOISOMERASE 1 AT THE NUCLEAR LAMINA TorsionAtLaminacoordinator175.5721
2020-06-01Beyond 1M Genomes B1MGparticipant4.000.00037
2020-02-01Infrastructure for transnational access and discovery in structural biology iNEXT-Discoverycoordinator9.987.74428
2020-01-01Photonics Solutions at Pilot Scale for Accelerated Medical Device Development MedPhabparticipant14.995.44520
2020-01-01CAncer PAtients Better Life Experience CAPABLEparticipant5.962.79312
2019-11-01Active Monitoring of Cancer As An Alternative To Surgery CASTparticipant4.102.37114
2019-09-15Microscopy of living cancer cells at physiological oxygen levels: the MICROX platform MICROXcoordinator281.3591
2019-09-01Breaking borders, Functional genetic screens of structural regulatory DNA elements Breakbordercoordinator2.497.0001
2019-03-01Joint Training and Research Program on Chromatin Dynamics and the DNA Damage Response aDDRessparticipant4.011.93919
2019-01-01Training network in drug discovery targeting TRIM Ubiquitin ligases in disease TRIM-NETparticipant3.203.44814
2019-01-01Project on Exercise for Fatigue Eradication in Advanced Breast cancer to improve quality of life PREFERABLEparticipant3.983.34712
2018-10-01Senescence therapy for cancer SENCANcoordinator2.478.7501
2018-04-01Cohesin-mediated chromosomal looping: From linear paths to 3D effects CohesinLoopingcoordinator1.998.3751
2018-02-01EurOPDX Distributed Infrastructure for Research on patient-derived cancer Xenografts EDIReXparticipant5.156.19919
2018-01-01Single-molecule visualization of transcription dynamics to understand regulatory mechanisms of transcriptional bursting and its effects on cellular fitness BURSTREGcoordinator1.950.7751
2017-12-01Sensitivity of human tumors to T cell attack SENSITcoordinator2.405.6251
2017-11-01Training Network on Automatic Processing of PAthological Speech TAPASparticipant3.856.02921
2017-06-01Implications of Medical Low Dose Radiation Exposure MEDIRADparticipant9.995.14635
2017-03-01Genomics of Chromosome Architecture and Dynamics in Single Cells GoCADiSCcoordinator2.497.1251
2017-01-01Regulated Assembly of Molecular Machines for DNA REPAIR: a Molecular Analysis training Network DNAREPAIRMANparticipant3.079.27014
2017-01-01Clinical proof of concept through a randomised phase II study: a combination of immunotherapy and stereotactic ablative radiotherapy as a curative treatment for limited metastatic lung cancer IMMUNOSABRparticipant5.994.17617
2017-01-01Towards enduring mouse resources and services advancing research into human health and disease INFRAFRONTIER2020participant4.955.87730
2016-10-01A global alliance for Zika virus control and prevention ZIKAllianceparticipant11.964.20956
2016-09-01Targeting SYNthetic lethal interactions for new cancer treatments TRAINing network SYNTRAINparticipant3.990.26913
2016-06-01Advancing Smart Optical Imaging and Sensing for Health ASTONISHparticipant5.895.04624
2016-05-01A treatment for BRAF inhibitor resistant melanoma 2MoveMate4Melanomaparticipant149.7501
2016-03-01Generation of the CanPath prototype - a platform for predictive cancer pathway modeling CanPathProparticipant9.862.5469
2016-01-01DC-based immunotherapy to treat Malignant Mesothelioma H2020MM04participant5.782.9658
2015-11-01World-wide E-infrastructure for structural biology West-Lifeparticipant3.981.12511
2015-10-01Molecularly guided trials with specific treatment strategies in patients with advanced newly molecular defined subtypes of colorectal cancer (MoTriColor) MoTriColorparticipant5.996.99211
2015-10-01Cancer treatment during pregnancy: from fetal safety to maternal efficacy CRADLEparticipant2.000.0002
2015-10-01Leading Innovative measures to reach gender Balance in Research Activities LIBRAparticipant2.291.64111
2015-09-01From haplotype to phenotype: a systems integration of allelic variation, chromatin state and 3D genome data HAP-PHENparticipant1.500.0001
2015-09-01Breast CAncer STratification: understanding the determinants of risk and prognosis of molecular subtypes B-CASTcoordinator5.983.35613
2015-09-01Tumor cell death supports recurrence of cancer Cancer-Recurrencecoordinator2.000.0002

overview shows latest 50 from 51 projects (2015-01-01 - 2022-12-31)
A full list of projects can be found here: